[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-354049-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-354049-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","the-effects-of-palbociclib-and-ferulic-acid-combination-on-cellular-processes-in-breast-cancer","The effects of Palbociclib and Ferulic acid combination on cellular processes in breast cancer","","Breast cancer remains a leading cause of cancer morbidity and mortality, creating a need for improved therapeutic options. This study evaluates the combined effects of palbociclib (PLB), a CDK4/6 inhibitor, and ferulic acid (FA), a natural antioxidant, on breast cancer cell lines MCF-7 and MDA-MB231 and on non-tumorigenic MCF-10A cells. Treatment suppresses cancer cell viability, migration, and proliferation more strongly than it affects MCF-10A.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/the-effects-of-palbociclib-and-ferulic-acid-combination-on-cellular-processes-in-breast-cancer/354049/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/the-effects-of-palbociclib-and-ferulic-acid-combination-on-cellular-processes-in-breast-cancer/354049.png","ImageObject",300,407,{"name":42,"@type":43},"Angel","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-30","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main goal of the study on palbociclib and ferulic acid?","Question",{"text":63,"@type":64},"To investigate how the combination of PLB and FA affects cellular processes in breast cancer cells and compares these effects with non-tumorigenic breast epithelial cells.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which cellular outcomes were evaluated after treatment?",{"text":68,"@type":64},"Cell viability, migration, cell cycle progression, oxidative stress, endoplasmic reticulum (ER) stress, mitochondrial membrane potential, and apoptosis were assessed.",{"name":70,"@type":61,"acceptedAnswer":71},"How does the combination treatment influence cancer cells versus non-tumorigenic cells?",{"text":72,"@type":64},"Both agents suppress proliferation in cancer cells more strongly, increase oxidative and lipid peroxidation levels, reduce mitochondrial membrane potential, and promote apoptosis, while these effects are comparatively limited or better preserved in MCF-10A cells.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},354049,1790584134,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},687207412472,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Bayav etal. Discover Oncology (2026) 17:597 [https://doi.org/10.1007/s12672-026-04779-7](https://doi.org/10.1007/s12672-026-04779-7)  \nDiscover Oncology  \nRESEARCH Open Access  \nThe effects of Palbociclib and Ferulic acid combination on cellular processes in breast cancer  \nIbrahim Bayav 1†, Pervin Elvan Tokgun2†, Huriye Ergezgin1 and Ayşe GayeTomatir1*  \n†Ibrahim Bayav and Pervin Elvan Tokgun contributed equally to this work.  \n*Correspondence:  \nAyşe GayeTomatir [tomatir@pau.edu.tr](tomatir@pau.edu.tr)[ ](tomatir@pau.edu.tr)1Department of Medical Biology, Faculty of Medicine, Pamukkale University, Kınıklı/Denizli, Denizli 20000, Turkey 2Department of Medical Genetics, Faculty of Medicine, Pamukkale University, Denizli 20000, Turkey  \nAbstract  \nBreast cancer remains a major cause of cancer-related morbidity and mortality worldwide, highlighting the urgent need for novel therapeutic approaches. In this study, we aimed to investigate the combined effects of Palbociclib (PLB), a cyclindependent kinase 4/6 (CDK4/6) inhibitor, and Ferulic Acid (FA), a natural antioxidant, on breast cancer cells (MCF-7 and MDA-MB231) as well as on non-tumorigenic breast epithelial cells (MCF-10 A) . To this end, the effects of PLB and FA on cell viability, migration, cell cycle progression, oxidative stress, endoplasmic reticulum (ER) stress, mitochondrial membrane potential (MMP), and apoptosis were evaluated. MTTassay results demonstrated that both agents, alone and in combination, significantly suppressed proliferation in cancer cells, whereas their impact on MCF-10 A cells was comparatively limited. In addition, oxidative stress and lipid peroxidation levels increased markedly in cancer cells following the combination treatment, while this increase was relatively restricted in MCF-10 A cells. MMP was significantly reduced in cancer cell lines under combination treatment, but was largely preserved in MCF-10 A cells. Molecular analyses revealed upregulation of ER stress markers (PERK, ATF-6, CHOP, IRE1, GRP78) and pro-apoptotic genes (BAX, Caspases, CYC-C), along with downregulation of the anti-apoptotic gene BCL-2 . Furthermore, phosphorylatedretinoblastoma protein (pRB) levels decreased significantly, indicating enhanced cell cycle arrest and chemosensitivity. Taken together, these findings suggest that the combination of PLB and FA exerts a anti-cancer effect by simultaneously inducing oxidative and ER stress, disrupting mitochondrial integrity, and promoting apoptosis in breast cancer cells, while sparing non-tumorigenic cells. This selective cytotoxicity underscores the therapeutic potential of PLB and FA as a promising combinational strategy for breast cancer treatment.  \nKeywords Palbociclib, Ferulic acid, Breast cancer, Oxidative stress, Endoplasmic reticulum stress, Apoptosis  \n1 Introduction  \nBreast cancer is the most common cancer that affects women, and has a significant mortality rate [1]. Breast cancer is treated using endocrine, surgical, chemotherapy and radiotherapy methods [2, 3]. Nevertheless, these treatment modalities have thus far  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtai","cbCaicoGdr3r8rGX","https://ap.wps.com/l/cbCaicoGdr3r8rGX","pdf",3249493,18,"English","# Abstract\n## Introduction","[{\"question\":\"What is the main goal of the study on palbociclib and ferulic acid?\",\"answer\":\"To investigate how the combination of PLB and FA affects cellular processes in breast cancer cells and compares these effects with non-tumorigenic breast epithelial cells.\"},{\"question\":\"Which cellular outcomes were evaluated after treatment?\",\"answer\":\"Cell viability, migration, cell cycle progression, oxidative stress, endoplasmic reticulum (ER) stress, mitochondrial membrane potential, and apoptosis were assessed.\"},{\"question\":\"How does the combination treatment influence cancer cells versus non-tumorigenic cells?\",\"answer\":\"Both agents suppress proliferation in cancer cells more strongly, increase oxidative and lipid peroxidation levels, reduce mitochondrial membrane potential, and promote apoptosis, while these effects are comparatively limited or better preserved in MCF-10A cells.\"}]","The effects of Palbociclib and Ferulic acid combination on cellular processes in breast cancer | PDF",1790108613,45,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/88d14539c3b22856f04877d44963ae8a.webp",983,1310,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fe56a7fb77573238057d2853e2e656f6.webp",982,1309,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3b37ceac4dd15e5d89dd408b40a51223.webp",981,1308,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/96e4c49e75f95163d903f897a62f93d3.webp",980,1306]